| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB PGM2L1 ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC FGGY ITK EPHA1 PTK7 TXK | 6.94e-14 | 709 | 74 | 21 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB PGM2L1 ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC FGGY ITK EPHA1 PTK7 TXK | 2.95e-13 | 764 | 74 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC ITK EPHA1 PTK7 TXK | 4.15e-13 | 600 | 74 | 19 | GO:0004672 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB PGM2L1 ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC FGGY ITK EPHA1 PTK7 TXK | 1.46e-11 | 938 | 74 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.24e-09 | 145 | 74 | 9 | GO:0004713 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 7.42e-07 | 46 | 74 | 5 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | ROCK2 MAST4 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ STK32C | 8.90e-07 | 363 | 74 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ROCK2 MAST4 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ STK32C | 5.60e-06 | 446 | 74 | 10 | GO:0004674 |
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 1.35e-05 | 2 | 74 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 5.32e-05 | 20 | 74 | 3 | GO:0004653 | |
| GeneOntologyMolecularFunction | transporter activity | SLC7A2 TMEM120B TMEM120A SLC7A3 TRPM5 OSBPL2 SLC16A4 KCNJ6 KCNJ8 KCNN4 BEST3 SLC12A8 LMBRD1 SLC47A2 UNC80 | 6.40e-05 | 1289 | 74 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 9.92e-05 | 65 | 74 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 1.35e-04 | 5 | 74 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 1.50e-04 | 28 | 74 | 3 | GO:0005242 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.80e-04 | 85 | 74 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 2.81e-04 | 7 | 74 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.93e-04 | 459 | 74 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 2.94e-04 | 35 | 74 | 3 | GO:0008376 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 3.09e-04 | 247 | 74 | 6 | GO:0000287 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC7A2 TMEM120B TMEM120A SLC7A3 TRPM5 SLC16A4 KCNJ6 KCNJ8 KCNN4 BEST3 SLC12A8 SLC47A2 UNC80 | 3.61e-04 | 1180 | 74 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.90e-04 | 167 | 74 | 5 | GO:0015079 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 4.80e-04 | 9 | 74 | 2 | GO:0004690 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 4.80e-04 | 9 | 74 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | AMP-activated protein kinase activity | 5.98e-04 | 10 | 74 | 2 | GO:0004679 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TMEM120B TMEM120A TRPM5 KCNJ6 KCNJ8 KCNN4 BEST3 SLC12A8 SLC47A2 UNC80 | 6.64e-04 | 793 | 74 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | 7.12e-04 | 525 | 74 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.21e-04 | 526 | 74 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.52e-04 | 193 | 74 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.25e-04 | 197 | 74 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 1.03e-03 | 13 | 74 | 2 | GO:0061459 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.31e-03 | 128 | 74 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 1.57e-03 | 16 | 74 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.78e-03 | 17 | 74 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.82e-03 | 140 | 74 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | endopeptidase activator activity | 2.22e-03 | 19 | 74 | 2 | GO:0061133 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 2.47e-03 | 20 | 74 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.52e-03 | 153 | 74 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 2.98e-03 | 22 | 74 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.63e-03 | 83 | 74 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.32e-03 | 288 | 74 | 5 | GO:0016757 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 4.48e-03 | 27 | 74 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 5.88e-03 | 31 | 74 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 6.45e-03 | 102 | 74 | 3 | GO:0005249 | |
| GeneOntologyMolecularFunction | small GTPase binding | 6.79e-03 | 321 | 74 | 5 | GO:0031267 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 7.84e-03 | 211 | 74 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.99e-03 | 334 | 74 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | fibronectin binding | 8.74e-03 | 38 | 74 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.90e-03 | 343 | 74 | 5 | GO:0005261 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | ROCK2 MAST4 NTRK2 RPS6KA2 PRKACA ROCK1 PRKCI AKT2 PRKCQ STK32C GALNT16 | 2.07e-08 | 319 | 75 | 11 | GO:0018209 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | ROCK2 MAST4 NTRK2 RPS6KA2 PRKACA ROCK1 PRKCI AKT2 PRKCQ STK32C | 1.63e-07 | 307 | 75 | 10 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | GALNTL6 ROCK2 MAST4 NDUFAF7 NTRK2 RPS6KA2 PRKACA ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C GALNT16 EPHA1 | 1.90e-06 | 976 | 75 | 15 | GO:0018193 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | ROCK2 TM7SF3 PRKACA SREBF2 KCNN4 PRKCI AKT2 PRKCQ TNFAIP6 WLS ECT2 | 9.05e-06 | 591 | 75 | 11 | GO:1903829 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.93e-05 | 228 | 75 | 7 | GO:0046777 | |
| GeneOntologyBiologicalProcess | interleukin-4 production | 2.55e-05 | 47 | 75 | 4 | GO:0032633 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin-activated signaling pathway | 7.79e-05 | 4 | 75 | 2 | GO:0110061 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 8.27e-05 | 122 | 75 | 5 | GO:0110020 | |
| GeneOntologyBiologicalProcess | negative regulation of meiotic cell cycle | 8.85e-05 | 24 | 75 | 3 | GO:0051447 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 9.27e-05 | 125 | 75 | 5 | GO:0018210 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.07e-04 | 403 | 75 | 8 | GO:1904951 | |
| GeneOntologyBiologicalProcess | regulation of bicellular tight junction assembly | 1.42e-04 | 28 | 75 | 3 | GO:2000810 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.91e-04 | 230 | 75 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | L-ornithine transmembrane transport | 1.94e-04 | 6 | 75 | 2 | GO:1903352 | |
| GeneOntologyBiologicalProcess | bicellular tight junction assembly | 2.17e-04 | 81 | 75 | 4 | GO:0070830 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 2.35e-04 | 239 | 75 | 6 | GO:0031032 | |
| GeneOntologyBiologicalProcess | negative regulation of bicellular tight junction assembly | 2.71e-04 | 7 | 75 | 2 | GO:1903347 | |
| GeneOntologyBiologicalProcess | ornithine transport | 2.71e-04 | 7 | 75 | 2 | GO:0015822 | |
| GeneOntologyBiologicalProcess | tight junction assembly | 2.98e-04 | 88 | 75 | 4 | GO:0120192 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 3.25e-04 | 90 | 75 | 4 | GO:0043297 | |
| GeneOntologyBiologicalProcess | L-arginine import across plasma membrane | 3.60e-04 | 8 | 75 | 2 | GO:0097638 | |
| GeneOntologyBiologicalProcess | response to DNA damage checkpoint signaling | 3.60e-04 | 8 | 75 | 2 | GO:0072423 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 3.82e-04 | 615 | 75 | 9 | GO:0002764 | |
| GeneOntologyBiologicalProcess | tight junction organization | 3.84e-04 | 94 | 75 | 4 | GO:0120193 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 4.21e-04 | 173 | 75 | 5 | GO:0072175 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 4.52e-04 | 499 | 75 | 8 | GO:0051345 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 4.67e-04 | 177 | 75 | 5 | GO:0030010 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | ROCK2 KCNJ6 TM7SF3 PRKACA SREBF2 KCNN4 PRKCI AKT2 PRKCQ TNFAIP6 WLS ECT2 | 5.21e-04 | 1087 | 75 | 12 | GO:0032880 |
| GeneOntologyBiologicalProcess | L-lysine transmembrane transport | 5.76e-04 | 10 | 75 | 2 | GO:1903401 | |
| GeneOntologyBiologicalProcess | L-lysine transport | 5.76e-04 | 10 | 75 | 2 | GO:1902022 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation via threonine | 5.76e-04 | 10 | 75 | 2 | GO:0018243 | |
| GeneOntologyBiologicalProcess | response to cell cycle checkpoint signaling | 5.76e-04 | 10 | 75 | 2 | GO:0072396 | |
| GeneOntologyBiologicalProcess | lung-associated mesenchyme development | 5.76e-04 | 10 | 75 | 2 | GO:0060484 | |
| GeneOntologyBiologicalProcess | response to DNA integrity checkpoint signaling | 5.76e-04 | 10 | 75 | 2 | GO:0072402 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 5.84e-04 | 105 | 75 | 4 | GO:0006493 | |
| GeneOntologyBiologicalProcess | cortical actin cytoskeleton organization | 5.87e-04 | 45 | 75 | 3 | GO:0030866 | |
| GeneOntologyBiologicalProcess | tube formation | 6.00e-04 | 187 | 75 | 5 | GO:0035148 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 6.27e-04 | 107 | 75 | 4 | GO:0051492 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 6.44e-04 | 190 | 75 | 5 | GO:0016331 | |
| GeneOntologyBiologicalProcess | CAMKK-AMPK signaling cascade | 7.02e-04 | 11 | 75 | 2 | GO:0061762 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 7.08e-04 | 194 | 75 | 5 | GO:0050714 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 7.38e-04 | 674 | 75 | 9 | GO:0070201 | |
| GeneOntologyBiologicalProcess | neural tube closure | 7.69e-04 | 113 | 75 | 4 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 7.95e-04 | 114 | 75 | 4 | GO:0060606 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta formation | 8.00e-04 | 50 | 75 | 3 | GO:1902003 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 8.48e-04 | 51 | 75 | 3 | GO:1990573 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 8.68e-04 | 203 | 75 | 5 | GO:0031214 | |
| GeneOntologyBiologicalProcess | export from cell | OSBPL2 KCNJ6 NTRK2 KCNJ8 SURF4 TM7SF3 PRKACA KCNN4 PRKCQ WLS SLC47A2 RIC1 | 8.76e-04 | 1153 | 75 | 12 | GO:0140352 |
| GeneOntologyBiologicalProcess | primary neural tube formation | 9.63e-04 | 120 | 75 | 4 | GO:0014020 | |
| GeneOntologyBiologicalProcess | positive regulation of connective tissue replacement | 9.92e-04 | 13 | 75 | 2 | GO:1905205 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle assembly | 9.92e-04 | 13 | 75 | 2 | GO:0034380 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 1.06e-03 | 123 | 75 | 4 | GO:0032231 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 1.06e-03 | 123 | 75 | 4 | GO:0045666 | |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 1.07e-03 | 319 | 75 | 6 | GO:0051222 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.10e-03 | 713 | 75 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | NK T cell differentiation | 1.15e-03 | 14 | 75 | 2 | GO:0001865 | |
| GeneOntologyBiologicalProcess | cortical cytoskeleton organization | 1.17e-03 | 57 | 75 | 3 | GO:0030865 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 1.19e-03 | 127 | 75 | 4 | GO:0043149 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 1.19e-03 | 127 | 75 | 4 | GO:0030038 | |
| GeneOntologyCellularComponent | Golgi membrane | GALNTL6 XYLT2 GALNT10 SURF4 SREBF2 ROCK1 PRKCI WLS GALNT16 NLRP3 RIC1 TMEM50B | 7.99e-06 | 721 | 74 | 12 | GO:0000139 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.80e-04 | 378 | 74 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | cAMP-dependent protein kinase complex | 5.46e-04 | 10 | 74 | 2 | GO:0005952 | |
| GeneOntologyCellularComponent | excitatory synapse | 5.67e-04 | 107 | 74 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | neuromuscular junction | 6.73e-04 | 112 | 74 | 4 | GO:0031594 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 2.01e-06 | 174 | 27 | 8 | HP:0009832 | |
| HumanPheno | Synostosis of carpal bones | 8.65e-06 | 26 | 27 | 4 | HP:0005048 | |
| HumanPheno | Decreased serum leptin | 2.13e-05 | 11 | 27 | 3 | HP:0003292 | |
| HumanPheno | Delayed eruption of teeth | 3.56e-05 | 185 | 27 | 7 | HP:0000684 | |
| HumanPheno | Abnormal circulating leptin concentration | 3.67e-05 | 13 | 27 | 3 | HP:0004361 | |
| HumanPheno | Conical incisor | 4.54e-05 | 39 | 27 | 4 | HP:0011065 | |
| HumanPheno | Carpal synostosis | 4.54e-05 | 39 | 27 | 4 | HP:0009702 | |
| HumanPheno | Abnormal toe phalanx morphology | 4.69e-05 | 130 | 27 | 6 | HP:0010161 | |
| HumanPheno | Upper airway obstruction | 1.03e-04 | 18 | 27 | 3 | HP:0002781 | |
| HumanPheno | Enlarged thorax | 1.13e-04 | 94 | 27 | 5 | HP:0100625 | |
| HumanPheno | Ankylosis | 1.22e-04 | 19 | 27 | 3 | HP:0031013 | |
| HumanPheno | Short limb dwarfism | 1.22e-04 | 19 | 27 | 3 | HP:0003505 | |
| HumanPheno | Synostosis of carpals/tarsals | 1.22e-04 | 50 | 27 | 4 | HP:0100266 | |
| HumanPheno | Dwarfism | 1.66e-04 | 21 | 27 | 3 | HP:0001516 | |
| HumanPheno | Conical tooth | 1.78e-04 | 55 | 27 | 4 | HP:0000698 | |
| HumanPheno | Abnormality of dental eruption | 1.86e-04 | 240 | 27 | 7 | HP:0006292 | |
| HumanPheno | Abnormal incisor morphology | 2.83e-04 | 62 | 27 | 4 | HP:0011063 | |
| HumanPheno | Abnormal external nose morphology | FLII ZMPSTE24 KCNJ6 KCNJ8 PRKACA PRKACB PGM2L1 FGFR2 WLS SLX4 UNC80 RIC1 DNMT3B | 3.13e-04 | 916 | 27 | 13 | HP:0010938 |
| HumanPheno | Short distal phalanx of finger | 3.42e-04 | 119 | 27 | 5 | HP:0009882 | |
| HumanPheno | Synostosis involving bones of the hand | 3.82e-04 | 67 | 27 | 4 | HP:0004278 | |
| HumanPheno | Prominent nasal tip | 3.98e-04 | 28 | 27 | 3 | HP:0005274 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanges of the hand | 4.14e-04 | 124 | 27 | 5 | HP:0009835 | |
| Domain | Prot_kinase_dom | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC ITK EPHA1 PTK7 TXK | 4.58e-14 | 489 | 75 | 19 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC ITK EPHA1 PTK7 TXK | 5.30e-14 | 493 | 75 | 19 | PS50011 |
| Domain | Protein_kinase_ATP_BS | ROCK2 TNK1 BMX NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC ITK EPHA1 TXK | 1.19e-13 | 379 | 75 | 17 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC ITK EPHA1 TXK | 2.02e-13 | 459 | 75 | 18 | PS00107 |
| Domain | Kinase-like_dom | ROCK2 TNK1 BMX MAST4 NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ FGFR2 STK32C TEC ITK EPHA1 PTK7 TXK | 2.87e-13 | 542 | 75 | 19 | IPR011009 |
| Domain | AGC-kinase_C | 1.08e-12 | 56 | 75 | 9 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.08e-12 | 56 | 75 | 9 | PS51285 | |
| Domain | S_TK_X | 1.08e-12 | 56 | 75 | 9 | SM00133 | |
| Domain | TyrKc | 7.33e-11 | 88 | 75 | 9 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 7.33e-11 | 88 | 75 | 9 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 1.78e-10 | 97 | 75 | 9 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.78e-10 | 97 | 75 | 9 | IPR008266 | |
| Domain | Pkinase_C | 3.05e-10 | 42 | 75 | 7 | PF00433 | |
| Domain | Pkinase_Tyr | 2.31e-09 | 129 | 75 | 9 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.19e-09 | 138 | 75 | 9 | IPR001245 | |
| Domain | Pkinase_C | 7.20e-09 | 37 | 75 | 6 | IPR017892 | |
| Domain | Ser/Thr_kinase_AS | ROCK2 MAST4 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ STK32C | 1.58e-06 | 357 | 75 | 10 | IPR008271 |
| Domain | S_TKc | ROCK2 MAST4 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ STK32C | 1.66e-06 | 359 | 75 | 10 | SM00220 |
| Domain | PROTEIN_KINASE_ST | ROCK2 MAST4 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ STK32C | 1.79e-06 | 362 | 75 | 10 | PS00108 |
| Domain | Pkinase | ROCK2 MAST4 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ STK32C | 2.83e-06 | 381 | 75 | 10 | PF00069 |
| Domain | BTK | 5.13e-06 | 9 | 75 | 3 | SM00107 | |
| Domain | Znf_Btk_motif | 5.13e-06 | 9 | 75 | 3 | IPR001562 | |
| Domain | BTK | 5.13e-06 | 9 | 75 | 3 | PF00779 | |
| Domain | ZF_BTK | 5.13e-06 | 9 | 75 | 3 | PS51113 | |
| Domain | ROCK1/ROCK2 | 1.59e-05 | 2 | 75 | 2 | IPR020684 | |
| Domain | TMPIT | 1.59e-05 | 2 | 75 | 2 | IPR012926 | |
| Domain | Rho_Binding | 1.59e-05 | 2 | 75 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 1.59e-05 | 2 | 75 | 2 | IPR015008 | |
| Domain | TMPIT | 1.59e-05 | 2 | 75 | 2 | PF07851 | |
| Domain | Cat_AA_permease | 4.76e-05 | 3 | 75 | 2 | IPR004755 | |
| Domain | AA-permease/SLC12A_dom | 9.07e-05 | 22 | 75 | 3 | IPR004841 | |
| Domain | AA_permease | 9.07e-05 | 22 | 75 | 3 | PF00324 | |
| Domain | PH | 1.26e-04 | 278 | 75 | 7 | SM00233 | |
| Domain | ZF_DAG_PE_1 | 1.27e-04 | 64 | 75 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.27e-04 | 64 | 75 | 4 | PS50081 | |
| Domain | PH_DOMAIN | 1.28e-04 | 279 | 75 | 7 | PS50003 | |
| Domain | PH_domain | 1.31e-04 | 280 | 75 | 7 | IPR001849 | |
| Domain | Ricin_B_lectin | 1.34e-04 | 25 | 75 | 3 | PF00652 | |
| Domain | C1 | 1.35e-04 | 65 | 75 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 1.43e-04 | 66 | 75 | 4 | IPR002219 | |
| Domain | CAT3 | 1.58e-04 | 5 | 75 | 2 | IPR015606 | |
| Domain | AA_permease_C | 1.58e-04 | 5 | 75 | 2 | PF13906 | |
| Domain | CAT_C | 1.58e-04 | 5 | 75 | 2 | IPR029485 | |
| Domain | RICIN | 1.90e-04 | 28 | 75 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 1.90e-04 | 28 | 75 | 3 | PS50231 | |
| Domain | Ricin_B_lectin | 2.34e-04 | 30 | 75 | 3 | IPR000772 | |
| Domain | Glycos_transf_2 | 2.34e-04 | 30 | 75 | 3 | PF00535 | |
| Domain | Glyco_trans_2-like | 2.34e-04 | 30 | 75 | 3 | IPR001173 | |
| Domain | PH | 3.16e-04 | 229 | 75 | 6 | PF00169 | |
| Domain | HR1 | 4.39e-04 | 8 | 75 | 2 | PF02185 | |
| Domain | SH2 | 7.29e-04 | 101 | 75 | 4 | PF00017 | |
| Domain | - | 9.76e-04 | 391 | 75 | 7 | 2.30.29.30 | |
| Domain | SH2 | 1.00e-03 | 110 | 75 | 4 | SM00252 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.02e-03 | 12 | 75 | 2 | PS00239 | |
| Domain | SH2 | 1.04e-03 | 111 | 75 | 4 | PS50001 | |
| Domain | SH2 | 1.07e-03 | 112 | 75 | 4 | IPR000980 | |
| Domain | - | 1.07e-03 | 112 | 75 | 4 | 3.30.505.10 | |
| Domain | AA_permease_2 | 1.21e-03 | 13 | 75 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 1.21e-03 | 13 | 75 | 2 | IPR002293 | |
| Domain | C1_1 | 1.56e-03 | 57 | 75 | 3 | PF00130 | |
| Domain | PH_dom-like | 1.60e-03 | 426 | 75 | 7 | IPR011993 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 1.84e-03 | 16 | 75 | 2 | IPR013518 | |
| Domain | IRK | 1.84e-03 | 16 | 75 | 2 | PF01007 | |
| Domain | - | 1.84e-03 | 16 | 75 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 1.84e-03 | 16 | 75 | 2 | IPR016449 | |
| Domain | DAG/PE-bd | 3.18e-03 | 21 | 75 | 2 | IPR020454 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 3.94e-06 | 98 | 61 | 6 | M39830 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 3.38e-05 | 15 | 61 | 3 | MM15103 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 8.12e-05 | 103 | 61 | 5 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 9.31e-05 | 106 | 61 | 5 | M27077 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.37e-04 | 115 | 61 | 5 | M9387 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 1.39e-04 | 184 | 61 | 6 | MM15943 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 1.57e-04 | 188 | 61 | 6 | M4844 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 1.83e-04 | 5 | 61 | 2 | M49031 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.83e-04 | 5 | 61 | 2 | M26988 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.83e-04 | 5 | 61 | 2 | MM15221 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.60e-04 | 29 | 61 | 3 | M27309 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 2.60e-04 | 29 | 61 | 3 | M39762 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 2.73e-04 | 6 | 61 | 2 | MM14628 | |
| Pathway | KEGG_O_GLYCAN_BIOSYNTHESIS | 2.88e-04 | 30 | 61 | 3 | M6929 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME | 3.81e-04 | 7 | 61 | 2 | M47896 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 3.81e-04 | 7 | 61 | 2 | MM15560 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.37e-04 | 532 | 61 | 9 | M27870 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 4.52e-04 | 83 | 61 | 4 | M39637 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.57e-04 | 35 | 61 | 3 | MM15109 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 4.95e-04 | 85 | 61 | 4 | M3578 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 4.97e-04 | 36 | 61 | 3 | M1315 | |
| Pathway | REACTOME_HDL_ASSEMBLY | 5.07e-04 | 8 | 61 | 2 | M27840 | |
| Pathway | WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION | 5.07e-04 | 8 | 61 | 2 | M48325 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 5.39e-04 | 37 | 61 | 3 | MM14488 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.83e-04 | 335 | 61 | 7 | MM14503 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 5.84e-04 | 38 | 61 | 3 | M495 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 6.14e-04 | 90 | 61 | 4 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 6.40e-04 | 91 | 61 | 4 | M39426 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 6.50e-04 | 9 | 61 | 2 | M47397 | |
| Pathway | REACTOME_ROBO_RECEPTORS_BIND_AKAP5 | 6.50e-04 | 9 | 61 | 2 | M27877 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY | 6.50e-04 | 9 | 61 | 2 | M47546 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 7.25e-04 | 165 | 61 | 5 | M39400 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 7.65e-04 | 575 | 61 | 9 | M29853 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY | 8.11e-04 | 10 | 61 | 2 | M47648 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 8.79e-04 | 99 | 61 | 4 | MM15905 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 9.00e-04 | 261 | 61 | 6 | MM15676 | |
| Pathway | SIG_CHEMOTAXIS | 9.61e-04 | 45 | 61 | 3 | M5193 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 9.88e-04 | 11 | 61 | 2 | MM15046 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 9.88e-04 | 11 | 61 | 2 | M47721 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 1.01e-03 | 267 | 61 | 6 | M10792 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 1.03e-03 | 46 | 61 | 3 | M39805 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 1.03e-03 | 46 | 61 | 3 | M46450 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.06e-03 | 104 | 61 | 4 | M39625 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 1.16e-03 | 48 | 61 | 3 | M39566 | |
| Pathway | WP_RAS_SIGNALING | 1.18e-03 | 184 | 61 | 5 | M39764 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 1.18e-03 | 12 | 61 | 2 | M27950 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE | 1.18e-03 | 12 | 61 | 2 | M27363 | |
| Pathway | KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.22e-03 | 108 | 61 | 4 | M9904 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.23e-03 | 49 | 61 | 3 | MM15448 | |
| Pathway | WP_FOCAL_ADHESION | 1.27e-03 | 187 | 61 | 5 | MM15913 | |
| Pathway | WP_DOPAMINE_METABOLISM | 1.39e-03 | 13 | 61 | 2 | M39622 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY | 1.39e-03 | 13 | 61 | 2 | M47547 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 1.39e-03 | 13 | 61 | 2 | M47731 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.47e-03 | 52 | 61 | 3 | M2341 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.47e-03 | 52 | 61 | 3 | M5785 | |
| Pathway | KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION | 1.58e-03 | 116 | 61 | 4 | M2164 | |
| Pathway | WP_FOCAL_ADHESION | 1.67e-03 | 199 | 61 | 5 | M39402 | |
| Pathway | PID_TXA2PATHWAY | 1.82e-03 | 56 | 61 | 3 | M99 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.85e-03 | 121 | 61 | 4 | M39823 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 1.87e-03 | 15 | 61 | 2 | MM15019 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 1.87e-03 | 15 | 61 | 2 | MM15037 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.87e-03 | 15 | 61 | 2 | M47794 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 1.87e-03 | 15 | 61 | 2 | M138 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.87e-03 | 15 | 61 | 2 | M47504 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.91e-03 | 411 | 61 | 7 | M735 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.10e-03 | 418 | 61 | 7 | MM15587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 2.13e-03 | 16 | 61 | 2 | M47551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.13e-03 | 16 | 61 | 2 | M47645 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.13e-03 | 16 | 61 | 2 | MM14699 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.13e-03 | 16 | 61 | 2 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.13e-03 | 16 | 61 | 2 | MM14492 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 2.13e-03 | 16 | 61 | 2 | M923 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 2.13e-03 | 16 | 61 | 2 | M40060 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.21e-03 | 60 | 61 | 3 | MM15636 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 2.40e-03 | 17 | 61 | 2 | M48086 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 2.40e-03 | 17 | 61 | 2 | MM15561 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 2.40e-03 | 17 | 61 | 2 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.40e-03 | 17 | 61 | 2 | M47544 | |
| Pathway | WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION | 2.40e-03 | 17 | 61 | 2 | M39907 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 2.40e-03 | 17 | 61 | 2 | MM15215 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.43e-03 | 62 | 61 | 3 | M546 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.78e-03 | 65 | 61 | 3 | MM14911 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | ADGRE3 RPS6KA2 SURF4 PRKACA PRKACB ROCK1 PRKCQ TNFAIP6 TEC NLRP3 ITK TXK | 2.88e-03 | 1128 | 61 | 12 | M1036 |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 2.90e-03 | 137 | 61 | 4 | M18155 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY | 3.00e-03 | 19 | 61 | 2 | M27841 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 3.00e-03 | 19 | 61 | 2 | M27493 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.04e-03 | 702 | 61 | 9 | M746 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.30e-03 | 69 | 61 | 3 | MM15596 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 3.33e-03 | 20 | 61 | 2 | M18415 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.33e-03 | 20 | 61 | 2 | M759 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 3.43e-03 | 70 | 61 | 3 | M41806 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 3.43e-03 | 70 | 61 | 3 | M3115 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.47e-03 | 144 | 61 | 4 | MM14501 | |
| Pathway | WP_BURN_WOUND_HEALING | 3.67e-03 | 21 | 61 | 2 | MM15978 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.67e-03 | 21 | 61 | 2 | M27485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.67e-03 | 21 | 61 | 2 | M47767 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 4.02e-03 | 22 | 61 | 2 | M42534 | |
| Pathway | WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION | 4.02e-03 | 22 | 61 | 2 | M48101 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 4.11e-03 | 151 | 61 | 4 | M19428 | |
| Pathway | WP_MAPK_SIGNALING | 4.17e-03 | 246 | 61 | 5 | M39597 | |
| Pubmed | 1.37e-11 | 83 | 77 | 8 | 11114734 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | TNK1 BMX NTRK2 RPS6KA2 PRKACB PRKCI AKT2 PRKCQ STK32C ITK EPHA1 | 6.43e-10 | 372 | 77 | 11 | 22939624 |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16424186 | ||
| Pubmed | Identification of phosphorylation sites within the SH3 domains of Tec family tyrosine kinases. | 1.04e-07 | 5 | 77 | 3 | 12573241 | |
| Pubmed | 1.04e-07 | 5 | 77 | 3 | 24722985 | ||
| Pubmed | 1.29e-07 | 21 | 77 | 4 | 22114277 | ||
| Pubmed | 1.29e-07 | 21 | 77 | 4 | 9671211 | ||
| Pubmed | 1.58e-07 | 22 | 77 | 4 | 9151826 | ||
| Pubmed | T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. | 2.08e-07 | 6 | 77 | 3 | 15662016 | |
| Pubmed | 3.75e-07 | 27 | 77 | 4 | 21651489 | ||
| Pubmed | Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. | 5.80e-07 | 8 | 77 | 3 | 15797222 | |
| Pubmed | Genetic modifiers of EGFR dependence in non-small cell lung cancer. | 8.68e-07 | 9 | 77 | 3 | 25512530 | |
| Pubmed | Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. | 1.70e-06 | 11 | 77 | 3 | 21423810 | |
| Pubmed | 1.91e-06 | 40 | 77 | 4 | 30898150 | ||
| Pubmed | SLC7A3 ZMPSTE24 KCNJ8 CHAC2 SREBF2 ROCK1 GLB1L2 TEC SCD5 WLS LMBRD1 SLX4 | 4.50e-06 | 1084 | 77 | 12 | 11544199 | |
| Pubmed | DPP9 RPS6KA2 PRKACA PRKACB MMP27 PRKCI AKT2 PRKCQ GALNT16 ITK | 4.83e-06 | 730 | 77 | 10 | 34857952 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 35523828 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29115372 | ||
| Pubmed | Investigation of the Rho-kinase Gene Polymorphism in Primary Open-angle Glaucoma. | 4.84e-06 | 2 | 77 | 2 | 24617500 | |
| Pubmed | [Ouabain induces Rho-dependent rock activation and membrane blebbing incultured endothelial cells]. | 4.84e-06 | 2 | 77 | 2 | 25916120 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12798690 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16237085 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 16514061 | ||
| Pubmed | PKCtheta and Itk functionally interact during primary mouse CD3+ T cell activation. | 4.84e-06 | 2 | 77 | 2 | 19682494 | |
| Pubmed | A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection. | 4.84e-06 | 2 | 77 | 2 | 10562318 | |
| Pubmed | Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. | 4.84e-06 | 2 | 77 | 2 | 3023318 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26468018 | ||
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 4.84e-06 | 2 | 77 | 2 | 22462535 | |
| Pubmed | Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction. | 4.84e-06 | 2 | 77 | 2 | 30165352 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32877952 | ||
| Pubmed | Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. | 4.84e-06 | 2 | 77 | 2 | 10213685 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29800294 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18668558 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 32234882 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15096457 | ||
| Pubmed | Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. | 4.84e-06 | 2 | 77 | 2 | 21189248 | |
| Pubmed | ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. | 4.84e-06 | 2 | 77 | 2 | 22934846 | |
| Pubmed | Functional role of Rho-kinase in ameloblast differentiation. | 4.84e-06 | 2 | 77 | 2 | 21792909 | |
| Pubmed | Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. | 4.84e-06 | 2 | 77 | 2 | 20803696 | |
| Pubmed | Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. | 4.84e-06 | 2 | 77 | 2 | 26481340 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18331468 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29211497 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30369081 | ||
| Pubmed | Tec family kinases modulate thresholds for thymocyte development and selection. | 4.84e-06 | 2 | 77 | 2 | 11015440 | |
| Pubmed | Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development. | 4.84e-06 | 2 | 77 | 2 | 23328676 | |
| Pubmed | The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. | 4.84e-06 | 2 | 77 | 2 | 18695890 | |
| Pubmed | Mutation of Tec family kinases alters T helper cell differentiation. | 4.84e-06 | 2 | 77 | 2 | 11702066 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24170433 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12508221 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18695640 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 15044207 | ||
| Pubmed | Differential regulation of adhesion complex turnover by ROCK1 and ROCK2. | 4.84e-06 | 2 | 77 | 2 | 22348083 | |
| Pubmed | Rho-associated kinase is a therapeutic target in neuroblastoma. | 4.84e-06 | 2 | 77 | 2 | 28739902 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25593320 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 36152045 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 38841868 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29246448 | ||
| Pubmed | Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction. | 4.84e-06 | 2 | 77 | 2 | 28679962 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17167780 | ||
| Pubmed | Association of Rho-kinase Gene Polymorphisms with Respiratory Distress Syndrome in Preterm Neonates. | 4.84e-06 | 2 | 77 | 2 | 27269648 | |
| Pubmed | Hyperoxia increases the elastic modulus of alveolar epithelial cells through Rho kinase. | 4.84e-06 | 2 | 77 | 2 | 24289040 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 17347801 | ||
| Pubmed | Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues. | 4.84e-06 | 2 | 77 | 2 | 22986902 | |
| Pubmed | Molecular and behavioral effects of a null mutation in all PKA C beta isoforms. | 4.84e-06 | 2 | 77 | 2 | 12139926 | |
| Pubmed | Activation of Rho kinase isoforms in lung endothelial cells during inflammation. | 4.84e-06 | 2 | 77 | 2 | 19201893 | |
| Pubmed | Human Txk: genomic organization, structure and contiguous physical linkage with the Tec gene. | 4.84e-06 | 2 | 77 | 2 | 8632917 | |
| Pubmed | Distinct roles for ROCK1 and ROCK2 in the regulation of keratinocyte differentiation. | 4.84e-06 | 2 | 77 | 2 | 19997641 | |
| Pubmed | TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation. | 4.84e-06 | 2 | 77 | 2 | 26024229 | |
| Pubmed | Role of Rho kinase isoforms in murine allergic airway responses. | 4.84e-06 | 2 | 77 | 2 | 21565918 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 2833513 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 34465718 | ||
| Pubmed | The Rho kinase pathway regulates mouse adult neural precursor cell migration. | 4.84e-06 | 2 | 77 | 2 | 21732490 | |
| Pubmed | Comparative Study of ROCK1 and ROCK2 in Hippocampal Spine Formation and Synaptic Function. | 4.84e-06 | 2 | 77 | 2 | 30826947 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 22205227 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26466958 | ||
| Pubmed | Sulfide induces apoptosis and Rho kinase-dependent cell blebbing in Jurkat cells. | 4.84e-06 | 2 | 77 | 2 | 23479079 | |
| Pubmed | Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. | 4.84e-06 | 2 | 77 | 2 | 19590140 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 24429217 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12778124 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 18495812 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28035042 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 25188917 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 30196430 | ||
| Pubmed | Global consequences of activation loop phosphorylation on protein kinase A. | 4.84e-06 | 2 | 77 | 2 | 19965870 | |
| Pubmed | Role of Rho-kinase in regulation of insulin action and glucose homeostasis. | 4.84e-06 | 2 | 77 | 2 | 16098829 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28709411 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 23838163 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 21471517 | ||
| Pubmed | Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. | 4.84e-06 | 2 | 77 | 2 | 25840982 | |
| Pubmed | ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. | 4.84e-06 | 2 | 77 | 2 | 16098146 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12180908 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 29987023 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 8772201 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 28928055 | ||
| Pubmed | Locus category based analysis of a large genome-wide association study of rheumatoid arthritis. | 4.84e-06 | 2 | 77 | 2 | 20639398 | |
| Pubmed | ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. | 4.84e-06 | 2 | 77 | 2 | 19131646 | |
| Pubmed | Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors. | 4.84e-06 | 2 | 77 | 2 | 31302146 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 20169147 | ||
| Pubmed | ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells. | 4.84e-06 | 2 | 77 | 2 | 30884801 | |
| Pubmed | Rho-associated kinases play a role in endocardial cell differentiation and migration. | 4.84e-06 | 2 | 77 | 2 | 15464581 | |
| Interaction | FYN interactions | PTPRD NTRK2 RPS6KA2 PRKACA PRKACB PRKCI PRKCQ FGFR2 PRPF8 ECT2 ITK TXK | 3.79e-08 | 431 | 72 | 12 | int:FYN |
| Interaction | PRKDC interactions | FLII RPS6KA2 PRKACA PRKACB ROCK1 AKT2 FGFR2 STK32C PRPF8 ECT2 SLX4 EPHA1 | 5.94e-06 | 695 | 72 | 12 | int:PRKDC |
| Interaction | HSP90AA1 interactions | TNK1 FLII BMX NTRK2 RPS6KA2 PRKACA PRKACB PRKCI AKT2 PRKCQ STK32C PRPF8 SLX4 NLRP3 ITK EPHA1 | 7.52e-06 | 1263 | 72 | 16 | int:HSP90AA1 |
| Interaction | CDC37 interactions | BMX NTRK2 RPS6KA2 PRKACA PRKCI AKT2 FGFR2 STK32C PRPF8 ITK EPHA1 | 1.70e-05 | 645 | 72 | 11 | int:CDC37 |
| Interaction | IL1RAP interactions | 1.82e-05 | 44 | 72 | 4 | int:IL1RAP | |
| Interaction | EPHA8 interactions | 3.15e-05 | 169 | 72 | 6 | int:EPHA8 | |
| Interaction | KCNMB3 interactions | 3.84e-05 | 53 | 72 | 4 | int:KCNMB3 | |
| Interaction | RPE interactions | 5.49e-05 | 58 | 72 | 4 | int:RPE | |
| Interaction | TBX21 interactions | 8.39e-05 | 24 | 72 | 3 | int:TBX21 | |
| Interaction | TCTN2 interactions | 1.06e-04 | 304 | 72 | 7 | int:TCTN2 | |
| Interaction | PIK3R1 interactions | 1.09e-04 | 412 | 72 | 8 | int:PIK3R1 | |
| Cytoband | 4p12 | 5.17e-04 | 20 | 77 | 2 | 4p12 | |
| Cytoband | 20q11.2 | 9.48e-04 | 27 | 77 | 2 | 20q11.2 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.48e-05 | 206 | 47 | 6 | 682 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 1.82e-05 | 20 | 47 | 3 | 433 | |
| GeneFamily | SH2 domain containing | 1.36e-04 | 101 | 47 | 4 | 741 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.52e-04 | 40 | 47 | 3 | 321 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 7.75e-04 | 16 | 47 | 2 | 276 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.02e-04 | 161 | 47 | 4 | 593 | |
| GeneFamily | Solute carriers | 3.50e-03 | 395 | 47 | 5 | 752 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL | 3.02e-06 | 412 | 76 | 9 | M45729 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP | 2.57e-05 | 200 | 76 | 6 | M7135 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 2.58e-05 | 20 | 76 | 3 | M1189 | |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 3.52e-05 | 354 | 75 | 8 | GSM605753_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 9.04e-05 | 405 | 75 | 8 | GSM605811_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.44e-04 | 75 | 75 | 4 | GSM605758_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 1.68e-04 | 78 | 75 | 4 | GSM605756_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 1.84e-04 | 336 | 75 | 7 | GSM538374_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.84e-04 | 336 | 75 | 7 | GSM605758_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | 1.91e-04 | 338 | 75 | 7 | GSM605763_500 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 1.91e-04 | 338 | 75 | 7 | GSM403987_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 1.94e-04 | 81 | 75 | 4 | GSM605781_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.Sp, 4+ 8- 25- 62Lhi 44lo, Spleen, avg-4 | 1.95e-04 | 339 | 75 | 7 | GSM538382_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 2.13e-04 | 344 | 75 | 7 | GSM538377_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 2.24e-04 | 84 | 75 | 4 | GSM476675_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 2.56e-04 | 87 | 75 | 4 | GSM476658_100 | |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | 2.67e-04 | 357 | 75 | 7 | GSM403986_500 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | 2.76e-04 | 359 | 75 | 7 | GSM404000_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 2.79e-04 | 89 | 75 | 4 | GSM476660_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3 | 3.00e-04 | 364 | 75 | 7 | GSM605766_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_200 | 5.05e-04 | 44 | 75 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_200 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.act.IEL, CD8a+ CD8b- TCRd+ Vg5- CD44hi, Small Intestine, avg-3 | 5.43e-04 | 402 | 75 | 7 | GSM605808_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 5.53e-04 | 289 | 75 | 6 | GSM399367_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.act.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44hi, Small Intestine, avg-3 | 6.10e-04 | 410 | 75 | 7 | GSM605802_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 6.14e-04 | 47 | 75 | 3 | GSM403995_100 | |
| CoexpressionAtlas | NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3 | 6.19e-04 | 411 | 75 | 7 | GSM538312_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 6.28e-04 | 412 | 75 | 7 | GSM605793_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 6.55e-04 | 415 | 75 | 7 | GSM605805_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 6.96e-04 | 302 | 75 | 6 | GSM399362_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 7.33e-04 | 423 | 75 | 7 | GSM476655_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3 | 7.33e-04 | 305 | 75 | 6 | GSM399394_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 7.80e-04 | 51 | 75 | 3 | GSM538374_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 8.26e-04 | 52 | 75 | 3 | GSM399382_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.MLN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 8.26e-04 | 52 | 75 | 3 | GSM538377_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 8.73e-04 | 53 | 75 | 3 | GSM538380_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3 | 8.73e-04 | 53 | 75 | 3 | GSM399370_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.Sp, 4+ 8- 25- 62Lhi 44lo, Spleen, avg-4 | 9.22e-04 | 54 | 75 | 3 | GSM538382_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4int8+.Th, 4int 8+ TCRhi, Thymus, avg-3 | 9.22e-04 | 54 | 75 | 3 | GSM399367_100 | |
| CoexpressionAtlas | CD positive, CD4 Test CJ, 4+8-B220-, Spleen, avg-2 | 9.73e-04 | 55 | 75 | 3 | GSM404003_100 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 9.73e-04 | 55 | 75 | 3 | GSM403994_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24int.Th, 4+ 8- TCRhi 24int, Thymus, avg-3 | 1.00e-03 | 324 | 75 | 6 | GSM399373_500 | |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | 1.03e-03 | 56 | 75 | 3 | GSM403986_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3 | 1.03e-03 | 56 | 75 | 3 | GSM399362_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 1.07e-03 | 328 | 75 | 6 | GSM605756_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.07e-03 | 127 | 75 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | 1.08e-03 | 57 | 75 | 3 | GSM605763_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3 | 1.08e-03 | 57 | 75 | 3 | GSM399394_100 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 1.14e-03 | 58 | 75 | 3 | GSM403987_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP69+.Th, 4- 8+ TCRhi 69+, Thymus, avg-3 | 1.14e-03 | 58 | 75 | 3 | GSM399385_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3 | 1.14e-03 | 58 | 75 | 3 | GSM538362_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 1.19e-03 | 59 | 75 | 3 | GSM399376_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3 | 1.19e-03 | 59 | 75 | 3 | GSM605766_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3 | 1.25e-03 | 60 | 75 | 3 | GSM538365_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3 | 1.25e-03 | 60 | 75 | 3 | GSM399379_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24int.Th, 4+ 8- TCRhi 24int, Thymus, avg-3 | 1.25e-03 | 60 | 75 | 3 | GSM399373_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3 | 1.25e-03 | 60 | 75 | 3 | GSM538371_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 1.26e-03 | 339 | 75 | 6 | GSM399382_500 | |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | 1.31e-03 | 61 | 75 | 3 | GSM404000_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.LN, CD8 TCRb CD44high CD122high, Lymph Node, avg-3 | 1.38e-03 | 62 | 75 | 3 | GSM538395_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3 | 1.51e-03 | 351 | 75 | 6 | GSM399379_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3 | 1.51e-03 | 64 | 75 | 3 | GSM538398_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 1.58e-03 | 65 | 75 | 3 | GSM538406_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 1.62e-03 | 356 | 75 | 6 | GSM538409_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3 | 1.65e-03 | 66 | 75 | 3 | GSM605770_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | 1.67e-03 | 780 | 75 | 9 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3 | 1.72e-03 | 67 | 75 | 3 | GSM538409_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 1.72e-03 | 67 | 75 | 3 | GSM538414_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 1.76e-03 | 362 | 75 | 6 | GSM605784_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP69+.Th, 4- 8+ TCRhi 69+, Thymus, avg-3 | 1.76e-03 | 362 | 75 | 6 | GSM399385_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_200 | 1.83e-03 | 147 | 75 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_200 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3 | 1.84e-03 | 365 | 75 | 6 | GSM399370_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | 1.84e-03 | 365 | 75 | 6 | GSM399376_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 1.88e-03 | 69 | 75 | 3 | GSM538413_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.Sp, 4- 8+ 25- 62Lhi 44lo, Spleen, avg-3 | 1.88e-03 | 69 | 75 | 3 | GSM538415_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 1.88e-03 | 69 | 75 | 3 | GSM538412_100 | |
| CoexpressionAtlas | CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3 | 1.95e-03 | 70 | 75 | 3 | GSM605909_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1 | 1.95e-03 | 70 | 75 | 3 | GSM605775_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 2.04e-03 | 71 | 75 | 3 | GSM605778_100 | |
| CoexpressionAtlas | NK cells, NK.DAP10-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 2.04e-03 | 71 | 75 | 3 | GSM538294_100 | |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | 2.04e-03 | 71 | 75 | 3 | GSM538288_100 | |
| CoexpressionAtlas | NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3 | 2.04e-03 | 71 | 75 | 3 | GSM538285_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PRSS35 SLC7A2 ZMPSTE24 SLC16A4 TM7SF3 FGFR2 GLB1L2 FGGY TMEM50B | 2.05e-03 | 804 | 75 | 9 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 2.12e-03 | 72 | 75 | 3 | GSM605787_100 | |
| CoexpressionAtlas | NK cells, NK.49H+.Sp, NK1.1+ Ly49H+, Spleen, avg-3 | 2.12e-03 | 72 | 75 | 3 | GSM605814_100 | |
| CoexpressionAtlas | NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3 | 2.12e-03 | 72 | 75 | 3 | GSM538312_100 | |
| CoexpressionAtlas | NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3 | 2.20e-03 | 73 | 75 | 3 | GSM538309_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4FP3+25+.Sp, 4+ 8- GFP+ 25+, Spleen, avg-3 | 2.20e-03 | 73 | 75 | 3 | GSM399365_100 | |
| CoexpressionAtlas | NK cells, NK.Sp, NK1.1+, Spleen, avg-3 | 2.20e-03 | 73 | 75 | 3 | GSM538315_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | 2.20e-03 | 73 | 75 | 3 | GSM399400_100 | |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 2.20e-03 | 73 | 75 | 3 | GSM538291_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.20e-03 | 73 | 75 | 3 | GSM605904_100 | |
| CoexpressionAtlas | NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3 | 2.29e-03 | 74 | 75 | 3 | GSM538297_100 | |
| CoexpressionAtlas | NK cells, NK.49H-.Sp, NK1.1+, Spleen, avg-3 | 2.29e-03 | 74 | 75 | 3 | GSM605817_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.31e-03 | 261 | 75 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | 2.38e-03 | 75 | 75 | 3 | GSM538300_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 2.38e-03 | 75 | 75 | 3 | GSM605753_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | 2.38e-03 | 75 | 75 | 3 | GSM538385_100 | |
| CoexpressionAtlas | NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | 2.38e-03 | 75 | 75 | 3 | GSM538303_100 | |
| CoexpressionAtlas | NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3 | 2.40e-03 | 385 | 75 | 6 | GSM538285_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 2.47e-03 | 76 | 75 | 3 | GSM605805_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 2.47e-03 | 76 | 75 | 3 | GSM538403_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3 | 2.47e-03 | 76 | 75 | 3 | GSM476681_100 | |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 2.56e-03 | 390 | 75 | 6 | GSM538291_500 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-08 | 192 | 76 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-08 | 194 | 76 | 7 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-07 | 174 | 76 | 6 | 5b00a795a9dd1a77305fcac5017cb276afdc1a27 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-07 | 174 | 76 | 6 | 3340b44c77f55244e3c2e2ea479d42563f937040 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.12e-07 | 178 | 76 | 6 | 28bb1e3e447261d0cb47e2b6343b17b2d74db525 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-07 | 179 | 76 | 6 | ac0c257e63a5994282d8b350c1b517cc3fbee52a | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-07 | 191 | 76 | 6 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.53e-07 | 192 | 76 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-06 | 195 | 76 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-06 | 195 | 76 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 200 | 76 | 6 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-06 | 158 | 76 | 5 | 9f0987eaf1766aadb5714b68df7a5d310ea5a57a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 159 | 76 | 5 | 94bc6ab248a8f02ccbc0facd24e0c7e9fda687d2 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-06 | 164 | 76 | 5 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-06 | 164 | 76 | 5 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-06 | 164 | 76 | 5 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 168 | 76 | 5 | 68ee3b3b012b56584e313813feb16e632e3f72d2 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-05 | 169 | 76 | 5 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-05 | 170 | 76 | 5 | d74fbd995a8a37fc237f7147d398357b811d6452 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-05 | 170 | 76 | 5 | 67e78e3c1d4cd3c6eaa5d0a9785b6cd8a3b08039 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 174 | 76 | 5 | fedadde222df1952d6456f4f3413c01579146e1f | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-05 | 174 | 76 | 5 | 262d14b42bc5ec2c8d5f33a1a0eb49a8e38dd0f0 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 174 | 76 | 5 | e69a011ae9698368923223d3af3243e609c08c83 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 174 | 76 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 175 | 76 | 5 | bf1ef77d5fed2135ac83a4f7e445ab59d1538696 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.24e-05 | 175 | 76 | 5 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 177 | 76 | 5 | 36da06ca9577cdb7c7b5114e604f6546b9765c08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 178 | 76 | 5 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 180 | 76 | 5 | 03e3067ee313e8c40b702b9bc9981f9859d045a2 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 180 | 76 | 5 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 181 | 76 | 5 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 181 | 76 | 5 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.54e-05 | 183 | 76 | 5 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 184 | 76 | 5 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 185 | 76 | 5 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 185 | 76 | 5 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 186 | 76 | 5 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 186 | 76 | 5 | 4dafc215c42e7949f932a3627359c107943b5d6b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 186 | 76 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 76 | 5 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 187 | 76 | 5 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 188 | 76 | 5 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.85e-05 | 190 | 76 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 191 | 76 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 191 | 76 | 5 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-05 | 192 | 76 | 5 | cd34defac6565d34db507918e791b09c79f7d1f8 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 192 | 76 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.14e-05 | 196 | 76 | 5 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 198 | 76 | 5 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 198 | 76 | 5 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 198 | 76 | 5 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 198 | 76 | 5 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 199 | 76 | 5 | 67d8c7e5356f5d409d4f98e8338cf6c499fd7aee | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | e4be88bcef2738915f711b32c95e9c613e7edf96 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 200 | 76 | 5 | 0e85c90719d9ec51a566e230c9dd2909d8df1f52 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 143 | 76 | 4 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.11e-04 | 145 | 76 | 4 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 147 | 76 | 4 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 149 | 76 | 4 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-04 | 149 | 76 | 4 | 68661c8facfb638560bb2e2c20d509941286dacb | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 149 | 76 | 4 | 4fda987bc7bb6d1dbd41b8f1f8c1bc59613255a8 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 150 | 76 | 4 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.33e-04 | 152 | 76 | 4 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 154 | 76 | 4 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 154 | 76 | 4 | 1c62290a2558fd6401b27de5a867d243b143b00a | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 157 | 76 | 4 | ad8c6eb34f5288288c4066119c17325afefbaafc | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 159 | 76 | 4 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 160 | 76 | 4 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 160 | 76 | 4 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 160 | 76 | 4 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 161 | 76 | 4 | cd4a736d0cec31477c6e8d3b07a04ede1559854b | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 161 | 76 | 4 | 28930ba576625b98cc15993d1499e9dc5edbb5a9 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 162 | 76 | 4 | b877b232f0a879a9058d81ad4730e7846484b7c3 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 162 | 76 | 4 | 7384a4dd38ed68ca02a72df6deff4d34c9694ce1 | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-04 | 162 | 76 | 4 | ccba6d8d644fe56060ad388ec3a062b7e3b9f086 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 162 | 76 | 4 | 9a18286e361e1dd18e6f943ce27db58b199fb6e4 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 162 | 76 | 4 | 66069146e2666d13c594bd76247893354a697c5d | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 162 | 76 | 4 | 3395e4dffdb9304d157c325e1fc0f12b433c7bd3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 162 | 76 | 4 | 9522af31f6b2f3cb81b6b84bd08353eea504d1d6 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-04 | 162 | 76 | 4 | 74cd0de957fdbe527656befd61f67d6814ce9e98 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 162 | 76 | 4 | 40265af9b36fd144a8577b8dacccd4fc0888a593 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 162 | 76 | 4 | 4b490989005bb03d4e7bbea01580f8548eff150f | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 162 | 76 | 4 | e4a09bf1a51710f6c57e6e01edf8b4619459d96d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 163 | 76 | 4 | 4dfd408aa700e307478ee35f6b902f68719d8d9e | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 163 | 76 | 4 | 801163c05f8fdacaebd0cb9b4c92741276bfa3e3 | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 163 | 76 | 4 | b1a38985d0560dbc6ca66f711d52a208303860ca | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 164 | 76 | 4 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 164 | 76 | 4 | e9e5a1462d8ed60b2e5bf603c8c47eb85bce83d5 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-04 | 164 | 76 | 4 | c2cd4e4b88cc1b80a9494f59d31339007ff824c1 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-HSC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.78e-04 | 164 | 76 | 4 | a35a0725b8bfe3cad5b85484217fd8a02bdee827 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-04 | 164 | 76 | 4 | d4d08353c7322f97ea07dd583b08661d635fff20 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 54706631d819f401988e2c733dd6e59401a3585d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 80f82aaab48791cb06fcb2d8ed7821f162742385 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 165 | 76 | 4 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 93ed399b8c6278e5f1528c07758fb502d80a1a8b | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 165 | 76 | 4 | 88745bf7ecb0f7fc93077cea20171d40535dd56b | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 28e3083ab90eb02141f844b7f8a218ec9c43dbf9 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 165 | 76 | 4 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 166 | 76 | 4 | 3213466380becf0ee3d4d9a0776ccbb1ee4eccea | |
| Drug | AH6809 | 8.31e-09 | 45 | 76 | 6 | CID000119461 | |
| Drug | BiM4 | ROCK2 NTRK2 RPS6KA2 PRKACA PRKACB KCNN4 ROCK1 PRKCI PRKCQ ITK | 3.48e-08 | 283 | 76 | 10 | CID000002399 |
| Drug | Nicorette | ROCK2 GDF5 FLII KCNJ6 NTRK2 KCNJ8 PRKACA PRKACB MMP27 ROCK1 PRKCI PRKCQ | 1.76e-07 | 529 | 76 | 12 | CID000000942 |
| Drug | potassium | ROCK2 SLC7A2 SLC7A3 TRPM5 KCNJ6 RPS6KA2 KCNJ8 PRKACA PRKACB KCNN4 ROCK1 PRKCI SLC12A8 AKT2 PRKCQ | 1.00e-06 | 1008 | 76 | 15 | CID000000813 |
| Drug | imatinib | 1.63e-06 | 430 | 76 | 10 | CID000005291 | |
| Drug | tautomycin | 2.77e-06 | 118 | 76 | 6 | CID000440646 | |
| Drug | AC1NSKHR | 4.93e-06 | 34 | 76 | 4 | CID005311362 | |
| Drug | damnacanthal | 4.93e-06 | 34 | 76 | 4 | CID000002948 | |
| Drug | glibenclamide | 5.07e-06 | 382 | 76 | 9 | CID000003488 | |
| Drug | Rockout | 1.10e-05 | 2 | 76 | 2 | CID000644354 | |
| Drug | 3,3-dimethylacryloyl chloride | 1.10e-05 | 2 | 76 | 2 | CID000102394 | |
| Drug | K 252 | 1.14e-05 | 88 | 76 | 5 | CID000003813 | |
| Drug | B-43 | 1.27e-05 | 14 | 76 | 3 | CID006603792 | |
| Drug | cBiMPS | 1.27e-05 | 14 | 76 | 3 | CID005487206 | |
| Drug | tetraethylammonium | 1.40e-05 | 236 | 76 | 7 | CID000005413 | |
| Drug | wartmannin | ROCK2 BMX NTRK2 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI AKT2 PRKCQ TEC ITK | 1.47e-05 | 811 | 76 | 12 | CID000005691 |
| Drug | NPC 15437 | 1.68e-05 | 46 | 76 | 4 | CID000004548 | |
| Drug | GDP-b-S | 1.71e-05 | 162 | 76 | 6 | CID000643998 | |
| Drug | Starlicide | 2.17e-05 | 49 | 76 | 4 | CID000007255 | |
| Drug | Zm 241385 | 2.17e-05 | 49 | 76 | 4 | CID000176407 | |
| Drug | 4 alpha-phorbol | 2.46e-05 | 103 | 76 | 5 | CID000028683 | |
| Drug | LY294002 | ROCK2 FLII NTRK2 RPS6KA2 PRKACA PRKACB SREBF2 ROCK1 PRKCI AKT2 TEC | 3.66e-05 | 748 | 76 | 11 | CID000003973 |
| Drug | tyrphostin 23 | 4.36e-05 | 116 | 76 | 5 | CID000002052 | |
| Drug | Rp-cAMPS | 4.72e-05 | 194 | 76 | 6 | CID006426631 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 5.00e-05 | 196 | 76 | 6 | 3971_DN | |
| Drug | 1,5-Isoquinolinediol; Up 200; 100uM; HL60; HG-U133A | 5.14e-05 | 197 | 76 | 6 | 543_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 3005_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.14e-05 | 197 | 76 | 6 | 2853_DN | |
| Drug | Sp-8-Cl-cAMPS | 5.26e-05 | 22 | 76 | 3 | CID000133987 | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; PC3; HT_HG-U133A | 5.29e-05 | 198 | 76 | 6 | 4258_UP | |
| Drug | Avermectin B1 [71751-41-2]; Up 200; 4.8uM; PC3; HT_HG-U133A | 5.44e-05 | 199 | 76 | 6 | 5864_UP | |
| Drug | sodium | SLC7A2 SLC7A3 TRPM5 KCNJ6 KCNJ8 PRKACA PRKACB KCNN4 PRKCI SLC12A8 PRKCQ PRPF8 | 6.47e-05 | 944 | 76 | 12 | CID000000923 |
| Drug | diguanosine pentaphosphate | 6.57e-05 | 4 | 76 | 2 | CID004577574 | |
| Drug | Pkcs | 7.52e-05 | 211 | 76 | 6 | CID000164073 | |
| Drug | ponatinib | 7.94e-05 | 68 | 76 | 4 | ctd:C545373 | |
| Drug | methacholine | 8.77e-05 | 217 | 76 | 6 | CID000001993 | |
| Drug | 4 alpha-phorbol 12,13-didecanoate | 8.89e-05 | 70 | 76 | 4 | CID000452543 | |
| Drug | sulprostone | 9.40e-05 | 71 | 76 | 4 | CID005312153 | |
| Drug | carbachol | ROCK2 KCNJ6 RPS6KA2 KCNJ8 PRKACA PRKACB KCNN4 ROCK1 PRKCI PRKCQ | 9.40e-05 | 688 | 76 | 10 | CID000002551 |
| Drug | K00077 | 9.46e-05 | 220 | 76 | 6 | CID006419759 | |
| Drug | calphostin C | 9.46e-05 | 431 | 76 | 8 | CID000002533 | |
| Drug | L-Lysine | 1.09e-04 | 5 | 76 | 2 | DB00123 | |
| Drug | tetrahydrooxazine | 1.09e-04 | 5 | 76 | 2 | CID000449101 | |
| Drug | DiC8 | 1.30e-04 | 146 | 76 | 5 | CID000001323 | |
| Drug | ML-9 | 1.34e-04 | 147 | 76 | 5 | CID000004217 | |
| Drug | butaprost | 1.36e-04 | 78 | 76 | 4 | CID005311035 | |
| Drug | barium | 1.38e-04 | 148 | 76 | 5 | CID000104810 | |
| Drug | GF109203X | 1.43e-04 | 341 | 76 | 7 | CID000002396 | |
| Drug | fasudil | 1.52e-04 | 151 | 76 | 5 | CID000003547 | |
| Drug | GTP[S] | 1.53e-04 | 591 | 76 | 9 | CID000001764 | |
| Drug | brazilein | 1.64e-04 | 6 | 76 | 2 | CID006453902 | |
| Drug | levormeloxifene | 1.64e-04 | 6 | 76 | 2 | ctd:C108255 | |
| Drug | AC1L1CTF | 1.64e-04 | 6 | 76 | 2 | CID000002056 | |
| Drug | nM-1 | 1.72e-04 | 155 | 76 | 5 | CID000445754 | |
| Drug | NSC611747 | 1.74e-04 | 352 | 76 | 7 | CID000002534 | |
| Drug | A61603 | 1.81e-04 | 33 | 76 | 3 | CID004038180 | |
| Drug | PDBu | 1.86e-04 | 249 | 76 | 6 | CID000037783 | |
| Drug | W7 hydrochloride | 1.90e-04 | 250 | 76 | 6 | CID000005681 | |
| Drug | dihydrochloride | 1.93e-04 | 159 | 76 | 5 | CID000070978 | |
| Drug | ON 01910 | 2.11e-04 | 162 | 76 | 5 | ctd:C507134 | |
| Drug | 6-BME | 2.28e-04 | 7 | 76 | 2 | CID005748218 | |
| Drug | AC1L2VEC | 2.28e-04 | 7 | 76 | 2 | CID000129320 | |
| Drug | 1,3-diolein | 2.36e-04 | 90 | 76 | 4 | CID000033120 | |
| Drug | NSC618487 | ROCK2 BMX KCNJ6 RPS6KA2 PRKACA PRKACB ROCK1 PRKCI PRKCQ FGFR2 ITK | 2.58e-04 | 933 | 76 | 11 | CID000005279 |
| Drug | lavendustin A | 2.71e-04 | 171 | 76 | 5 | CID000003894 | |
| Drug | EIPA | 2.90e-04 | 95 | 76 | 4 | CID000001795 | |
| Drug | 12-deoxyphorbol 13-isobutyrate | 3.00e-04 | 39 | 76 | 3 | CID000107855 | |
| Drug | GGTI-297 | 3.04e-04 | 8 | 76 | 2 | CID009956145 | |
| Drug | heptenoic acid | 3.04e-04 | 8 | 76 | 2 | CID000029373 | |
| Drug | N-palmitoyl-serine | 3.04e-04 | 8 | 76 | 2 | CID000085997 | |
| Drug | oxethazaine | 3.04e-04 | 8 | 76 | 2 | CID000004621 | |
| Drug | SC-46275 | 3.04e-04 | 8 | 76 | 2 | CID005311427 | |
| Drug | Y-26763 | 3.04e-04 | 8 | 76 | 2 | CID000121878 | |
| Drug | 1d3q | 3.23e-04 | 40 | 76 | 3 | CID000001635 | |
| Drug | glycitein | 3.27e-04 | 98 | 76 | 4 | ctd:C086566 | |
| Drug | OD-q | 3.34e-04 | 179 | 76 | 5 | CID000001456 | |
| Drug | Reidispongiolide C | 3.42e-04 | 279 | 76 | 6 | CID005289285 | |
| Drug | antibiotic from Streptomyces | 3.74e-04 | 42 | 76 | 3 | CID000005153 | |
| Drug | P6Chol | 3.90e-04 | 9 | 76 | 2 | CID000126085 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 3.98e-04 | 186 | 76 | 5 | 6996_UP | |
| Drug | Ro 31-8830 | 4.09e-04 | 104 | 76 | 4 | CID000005084 | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.18e-04 | 188 | 76 | 5 | 3257_DN | |
| Drug | KT5720 | 4.29e-04 | 189 | 76 | 5 | CID000003844 | |
| Drug | SC-560 | 4.29e-04 | 44 | 76 | 3 | CID004306515 | |
| Drug | AC1OAGFB | 4.30e-04 | 539 | 76 | 8 | CID006857345 | |
| Drug | Go6976 | 4.39e-04 | 190 | 76 | 5 | CID000003501 | |
| Drug | FTI-277 | 4.40e-04 | 106 | 76 | 4 | CID003005531 | |
| Drug | 20-HETE | 4.40e-04 | 106 | 76 | 4 | CID005283157 | |
| Drug | Potassium | 4.40e-04 | 106 | 76 | 4 | ctd:D011188 | |
| Drug | phosphine oxide | 4.56e-04 | 107 | 76 | 4 | CID000166931 | |
| Drug | AC1L1E8W | 4.56e-04 | 107 | 76 | 4 | CID000002691 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.61e-04 | 192 | 76 | 5 | 3929_DN | |
| Drug | nifedipine | 4.71e-04 | 415 | 76 | 7 | CID000004485 | |
| Drug | A13108 | 4.86e-04 | 10 | 76 | 2 | CID000062278 | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2942_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 3909_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 2761_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 1704_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 4.94e-04 | 195 | 76 | 5 | 7559_UP | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 5.06e-04 | 196 | 76 | 5 | 5488_UP | |
| Disease | Metastatic melanoma | 1.11e-05 | 54 | 75 | 4 | C0278883 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.07e-05 | 24 | 75 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.07e-05 | 24 | 75 | 3 | C3805278 | |
| Disease | FEV change measurement, response to zileuton | 3.48e-05 | 25 | 75 | 3 | EFO_0005921, EFO_0007676 | |
| Disease | tyrosine-protein kinase TEC measurement | 3.81e-05 | 4 | 75 | 2 | EFO_0020830 | |
| Disease | Cholangiocarcinoma | 3.93e-05 | 26 | 75 | 3 | C0206698 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 1.06e-04 | 36 | 75 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 1.07e-04 | 96 | 75 | 4 | C1319315 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.94e-04 | 44 | 75 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | ceramide measurement | 3.37e-04 | 235 | 75 | 5 | EFO_0010222 | |
| Disease | Vertigo | 4.42e-04 | 139 | 75 | 4 | HP_0002321 | |
| Disease | cystathionine measurement | 1.06e-03 | 19 | 75 | 2 | EFO_0010474 | |
| Disease | Nystagmus | 1.30e-03 | 21 | 75 | 2 | HP_0000639 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 1.56e-03 | 23 | 75 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.56e-03 | 195 | 75 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 18:0 measurement | 1.70e-03 | 24 | 75 | 2 | EFO_0010359 | |
| Disease | endometriosis (is_marker_for) | 1.84e-03 | 25 | 75 | 2 | DOID:289 (is_marker_for) | |
| Disease | prostate carcinoma | 1.90e-03 | 891 | 75 | 8 | EFO_0001663 | |
| Disease | blood rubidium measurement | 1.99e-03 | 26 | 75 | 2 | EFO_0021529 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.15e-03 | 27 | 75 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 2.20e-03 | 525 | 75 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.20e-03 | 525 | 75 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 2.24e-03 | 527 | 75 | 6 | C1458155 | |
| Disease | lysophosphatidylethanolamine 22:6 measurement | 2.31e-03 | 28 | 75 | 2 | EFO_0010371 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.45e-03 | 105 | 75 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 2.49e-03 | 538 | 75 | 6 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGLSGSDFPDEEWLW | 366 | Q8N1M1 | |
| DYGRAVDWWGLGVVM | 326 | P31751 | |
| TGDRGIMDEDGYFWW | 451 | Q6P461 | |
| ASDVWSFGIVMWEVL | 806 | P21709 | |
| SLELLFSDWGMEWAQ | 51 | Q8N9T2 | |
| SGMRWVQWFGDGKFS | 256 | Q9UBC3 | |
| WAFGILMWEVFSLGK | 596 | P51813 | |
| ADTWVRFSIWMAIGF | 581 | P52569 | |
| IWGGENFELSFRVWM | 316 | Q8N428 | |
| TGGLAWWNDFMVLAC | 541 | Q4ADV7 | |
| WFWGSIQMDARAGET | 336 | Q9H8V3 | |
| VWSFGVLMWEIFTLG | 686 | P21802 | |
| FVGIWCWRFDEMTQT | 391 | Q9H306 | |
| DWWALGVLIYEMAAG | 221 | P17612 | |
| GFSVDWWALGVLMFE | 431 | P41743 | |
| DWWSFGVLLYEMLIG | 561 | Q04759 | |
| FWQGREASNMGWLTF | 986 | Q13045 | |
| LDGSGWEVFDIWKLF | 286 | P43026 | |
| LFAIMWWLVAFAHGD | 86 | Q15842 | |
| VLHAEMLWFGGCSWA | 41 | O15554 | |
| FFGMIWWLIAYIRGD | 106 | P48051 | |
| VMAGGLFAVDRKWFW | 316 | Q86SR1 | |
| SMAGIRNIGIWFFWI | 381 | Q9NUN5 | |
| VFTGNELAALFGWWM | 351 | Q6PCE3 | |
| ISMACVGFFWLQGAW | 6 | Q14952 | |
| ALMFADGWQAGLGTW | 961 | Q96RT8 | |
| DETWILFLPMEWGDS | 76 | Q9HB29 | |
| MAVDVEFGVAGWWEA | 1 | Q5W5W9 | |
| DWWALGVLIYEMAAG | 221 | P22694 | |
| GWTRDGKYAWAMFLD | 356 | Q86TI2 | |
| GWDDSFWKMIGLEDF | 201 | Q96C11 | |
| WWAMGIILYEFLVGC | 766 | O15021 | |
| GWNFMLEDSTFWIFG | 51 | Q8IW92 | |
| DNLGFPVSDWLFSMW | 441 | O75844 | |
| LFMWEPVLFGTWDGV | 31 | A0AV02 | |
| TWARFGVWMLIGFAI | 566 | Q8WY07 | |
| SLPETFGDFWRMIWE | 1431 | P23468 | |
| VWSFGVLMWEVFSEG | 541 | Q08881 | |
| FNGEEKAWAMAVWIF | 61 | Q96P20 | |
| VMAGGLFAVDRKWFW | 311 | Q49A17 | |
| WWAYEIGSFLMGLLS | 306 | Q86VL8 | |
| TVEGFQSWMWRGLTF | 256 | A0PK00 | |
| VEGFQSWMWRGLTFL | 261 | Q9BXJ8 | |
| SDVWSFGVLMWEVFT | 546 | P42680 | |
| IFGELLGIWFISEWM | 96 | Q7L592 | |
| WFIDFMCWLGLATDR | 296 | Q86SK9 | |
| TFLEDGIRMWFQWSE | 36 | O15260 | |
| YMHLVWGSWGLGFLD | 141 | Q8NH09 | |
| FMIYGKWTECLWGID | 296 | Q9H1P3 | |
| WEGSALTGAWAMEDF | 531 | Q8IY92 | |
| GYSFEVDWWSVGVMA | 271 | Q86UX6 | |
| CWLHLDQGFMWSFLG | 496 | Q9BY15 | |
| TAAIAGCWWGVMYGF | 306 | P54922 | |
| MWVFGYGSLIWKVDF | 1 | Q8WUX2 | |
| AMARLWGFCWLVVGF | 11 | Q16620 | |
| AAGWRVWLFFMRGIT | 631 | Q6P2Q9 | |
| LGFCISWFLVWMDGV | 96 | Q5SV17 | |
| SWFLVWMDGVLHCAV | 101 | Q5SV17 | |
| LWEDTQGWGFKDGIF | 11 | P98066 | |
| WGMDAISATLTFLWE | 1946 | Q8N2C7 | |
| WGIFTNDFWGKGMAE | 71 | Q8IUR5 | |
| AFLTRIWWGDMAAGT | 631 | Q9NZQ8 | |
| DGGWGWMIVIHFFLV | 16 | O15374 | |
| FTPGWTLIDGSEMEW | 11 | Q8N3Z0 | |
| VLSFESGSGGWFDWM | 521 | Q12772 | |
| GILFFTGWWIMIDAA | 31 | P56557 | |
| DWWSVGVFLYEMLVG | 276 | O75116 | |
| DFILAVLWAVVWFMG | 106 | O95473 | |
| WWSVGVFLYEMLVGD | 261 | Q13464 | |
| KSDVWSFGVLMWEVF | 446 | P42681 | |
| VTLWEMFSGGEEPWA | 311 | Q13470 | |
| WFSIGFDWTWMLLFG | 286 | Q5T9L3 | |
| FDWTWMLLFGDIRQG | 291 | Q5T9L3 | |
| KSDVWAFGVLMWEVF | 986 | Q13308 | |
| MRDLLEVPGWAWDFF | 311 | Q9H1B5 | |
| PFGQWWASVGMDDFL | 511 | Q9H808 | |
| SVGGMFLVAVWWRFG | 356 | Q9NS93 | |
| DWWSFGVLMFEMLTG | 241 | Q15349 |